Statins for all? A question for societyBMJ 2014; 349 doi: https://doi.org/10.1136/bmj.g4192 (Published 09 July 2014) Cite this as: BMJ 2014;349:g4192
- David Barer, geriatrician/stroke physician1
- 1South of Tyne and Wear Stroke Collaboration, Sunderland Royal Hospital, Sunderland SR4 7TP, UK
The debate about extending the use of statins to those with an (unreliably) estimated 1% annual risk of cardiovascular disease is degenerating into an unseemly row about side effects,1 2 3 largely promoted by the tabloid press on one side and drug companies on the other. This is a dispute that the medical profession should keep out of, at least until the relevant evidence is …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial